The Evolving Indications for Reverse Total Shoulder Arthroplasty

    3 experts in shoulder surgery answer questions about their indications for and experience with the procedure since the rTSA prosthesis was approved by the FDA.

    For about a decade, orthopaedic surgeons in the United States have been performing reverse total shoulder arthroplasty (rTSA) following approval of the rTSA prosthesis by the US Food and Drug Administration in 2004.

    The original indication for rTSA was rotator cuff arthropathy, but in the past decade, the use has expanded to such conditions as massive rotator cuff tears, failed shoulder arthroplasty, and shoulder fracture sequelae. Some surgeons continue to push the boundaries and explore ever-expanding indications for the prosthesis in an effort to find solutions to their patients’ increasingly complex shoulder issues.

    At the International Congress for Joint Reconstruction’s 3rd Annual Las Vegas Shoulder Course, we spoke with a number of faculty members about their indications for and experience with rTSA. Click on the video viewers below to hear what 3 of these experts – Sumant “Butch” Krishnan, MD; T. Bradley Edwards, MD; and Matthew Ramsey, MD – had to say about rTSA.

    Current indications

    Your indications

    Future indications

    Producer: Susan Doan-Johnson; Director and Post-Production: Charles Maynard